TecDAX

The fate of CureVac hangs in the balance as shareholders approach a critical decision point regarding BioNTech's acquisition proposal. With...

Sysmex Corporation finds itself navigating turbulent market conditions as its stock value continues to deteriorate. Despite receiving an unexpected analyst...

Technology provider ePlus is approaching a pivotal moment this week, with its upcoming quarterly earnings report set to serve as...

Lam Research Corporation continues its impressive market performance, reaching unprecedented valuation levels driven by exceptional quarterly results and surging demand...

Semiconductor manufacturer Wolfspeed jolted investors with a sobering financial forecast, triggering a sharp decline in its share price. Despite reporting...

Time is running out for investors in CureVac as they approach a decisive moment in the company's proposed acquisition by...

While artificial intelligence dominates technology headlines, the real value often lies with the companies building the foundational infrastructure. Lumentum Holdings...

SolarEdge Technologies is approaching a pivotal moment as the company prepares to release its third-quarter financial results this Wednesday before...

German biotechnology firm BioNTech has initiated a significant strategic shift with its $1.25 billion acquisition of competitor CureVac, marking a...

The landscape of mRNA biotechnology is poised for a significant transformation as BioNTech has officially commenced its takeover bid for...